Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Schick

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 14, 2011
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?Thomas Zilli, Ulrike Schick, Mahmut Ozsahin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2025
Stereotactic radiotherapy for prostate cancerUlrike Schick, Delphine Antoni, Stéphanie Josset, et al.
Oral Oncology|July 24, 2014
Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsilJoanna Lynch, Punita Lal, Ulrike Schick, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 2, 2021
PD-L1 expression in recurrent head and neck squamous cell carcinomaAlice Delafoy, Arnaud Uguen, Gilles Lemasson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 12, 2020
PD-L1 Copy Number Variation Does Not Correlate With PD-L1 Expression or Response to Anti-PD-1 Immunotherapy In Patients With Advanced MelanomasJérémy Pérottet, Emeline Le Goff, Delphine Legoupil, et al.
Human Pathology|November 27, 2020
Breast cancer tumor heterogeneity has only little impact on the estimation of the Oncotype DX® recurrence score using Magee Equations and Magee Decision Algorithm™Annabelle Remoué, Virginie Conan-Charlet, Laura Deiana, et al.
Rare Tumors|October 18, 2016
Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network StudyGamze Ugurluer, Robert C Miller, Yexiong Li, et al.
BMC Cancer|October 14, 2020
Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastasesMorgan Guénolé, François Lucia, Vincent Bourbonne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2025
Stereotactic radiotherapy for lung cancer: Influence of prescription modality on clinical outcomeDelphine Antoni, Ulrike Schick, Delphine Jarnet, et al.
Frontiers in Oncology|May 28, 2020
Use of Baseline <sup></sup> F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical CancerFrançois Lucia, Omar Miranda, Ronan Abgral, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 14, 2011
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?Thomas Zilli, Ulrike Schick, Mahmut Ozsahin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2025
Stereotactic radiotherapy for prostate cancerUlrike Schick, Delphine Antoni, Stéphanie Josset, et al.
Oral Oncology|July 24, 2014
Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsilJoanna Lynch, Punita Lal, Ulrike Schick, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 2, 2021
PD-L1 expression in recurrent head and neck squamous cell carcinomaAlice Delafoy, Arnaud Uguen, Gilles Lemasson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 12, 2020
PD-L1 Copy Number Variation Does Not Correlate With PD-L1 Expression or Response to Anti-PD-1 Immunotherapy In Patients With Advanced MelanomasJérémy Pérottet, Emeline Le Goff, Delphine Legoupil, et al.
Human Pathology|November 27, 2020
Breast cancer tumor heterogeneity has only little impact on the estimation of the Oncotype DX® recurrence score using Magee Equations and Magee Decision Algorithm™Annabelle Remoué, Virginie Conan-Charlet, Laura Deiana, et al.
Rare Tumors|October 18, 2016
Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network StudyGamze Ugurluer, Robert C Miller, Yexiong Li, et al.
BMC Cancer|October 14, 2020
Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastasesMorgan Guénolé, François Lucia, Vincent Bourbonne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2025
Stereotactic radiotherapy for lung cancer: Influence of prescription modality on clinical outcomeDelphine Antoni, Ulrike Schick, Delphine Jarnet, et al.
Frontiers in Oncology|May 28, 2020
Use of Baseline <sup></sup> F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical CancerFrançois Lucia, Omar Miranda, Ronan Abgral, et al.
Pageof 15